Skip to main content

Site notifications

AusPAR: Tecentriq

AusPAR
Device/Product Name
Tecentriq
Active ingredients
Atezolizumab
AusPAR Date
Published
Submission Number
PM-2019-05906-1-4
Submission Type
Extension of indications
Decision
Withdrawn